Tag: vaccinemandate

Full FDA approval of Pfizer’s and Moderna’s COVID-19 shots would reinvigorate the U.S. vaccination push — but it could still be months away

The “full” approval of Pfizer’s and Moderna’s COVID-19 vaccines will almost certainly boost sagging vaccination rates in the U.S., though the Food and Drug Administration’s decision might not come until the end of the year. The Pfizer Inc. PFE, +0.43% and Moderna Inc. MRNA, -0.34% vaccines, along with Johnson & Johnson’s JNJ, +1.82% COVID-19 shot, […]

Read More